Actionable pathogenic variant detection in breast cancer genes
Actionable pathogenic variant detection in breast cancer genes
MINDACT: 70-gene signature test as guidance for breast cancer treatment
ESMO 2020 melanoma roundup
Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma
ESMO 2020: Lung cancer latest
Highlights from ESMO 2020
PARP inhibitors and their evolving role for the treatment of prostate cancer
OncoAlert and ecancer weekly roundup for September 14-19, 2020
Latest updates to the ESMO bone health guidelines
Estimate of the 2-year oncology workload generated by each new patient: A real-world study
MonarchE: Abemaciclib plus endocrine therapy in high-risk early breast cancer
Personalised molecularly matched therapies for carcinomas of unknown primary